Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:476
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 50 条
  • [21] Harms and benefits of mammographic screening for breast cancer in Brazil
    Migowski, Arn
    Nadanovsky, Paulo
    Vianna, Cid Manso de Mello
    PLOS ONE, 2024, 19 (01):
  • [22] Collaborative Modeling of the Benefits and Harms Associated With Different US Breast Cancer Screening Strategies
    Mandelblatt, Jeanne S.
    Stout, Natasha K.
    Schechter, Clyde B.
    van den Broek, Jeroen J.
    Miglioretti, Diana L.
    Krapcho, Martin
    Trentham-Dietz, Amy
    Munoz, Diego
    Lee, Sandra J.
    Berry, Donald A.
    van Ravesteyn, Nicolien T.
    Alagoz, Oguzhan
    Kerlikowske, Karla
    Tosteson, Anna N. A.
    Near, Aimee M.
    Hoeffken, Amanda
    Chang, Yaojen
    Heijnsdijk, Eveline A.
    Chisholm, Gary
    Huang, Xuelin
    Huang, Hui
    Ergun, Mehmet Ali
    Gangnon, Ronald
    Sprague, Brian L.
    Plevritis, Sylvia
    Feuer, Eric
    de Koning, Harry J.
    Cronin, Kathleen A.
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (04) : 215 - +
  • [23] The benefits and harms of breast cancer screening: an independent review
    Marmot, M. G.
    Altman, D. G.
    Cameron, D. A.
    Dewar, J. A.
    Thompson, S. G.
    Wilcox, M.
    BRITISH JOURNAL OF CANCER, 2013, 108 (11) : 2205 - 2240
  • [24] Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses
    Braithwaite, Dejana
    Walter, Louise C.
    Izano, Monika
    Kerlikowske, Karla
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2016, 31 (05) : 561 - 572
  • [25] Health benefits and harms of mammography screening in older women (75+years)-a systematic review
    Mathieu, Erin
    Noguchi, Naomi
    Li, Tong
    Barratt, Alexandra L.
    Hersch, Jolyn K.
    De Bock, Geertruida H.
    Wylie, Elizabeth J.
    Houssami, Nehmat
    BRITISH JOURNAL OF CANCER, 2023, 130 (2) : 275 - 296
  • [26] Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates
    Lew, Jie-Bin
    Feletto, Elenora
    Wade, Stephen
    Caruana, Michael
    Kang, Yoon-Jung
    Nickson, Carolyn
    Simms, Kate T.
    Procopio, Pietro
    Taylor, Natalie
    Worthington, Oachim
    Smith, David P.
    Canfell, Karen
    PUBLIC HEALTH RESEARCH & PRACTICE, 2019, 29 (02):
  • [27] Comparative Effectiveness of Alternative Prostate-Specific Antigen-Based Prostate Cancer Screening Strategies Model Estimates of Potential Benefits and Harms
    Gulati, Roman
    Gore, John L.
    Etzioni, Ruth
    ANNALS OF INTERNAL MEDICINE, 2013, 158 (03) : 145 - +
  • [28] Harms of screening mammography for breast cancer in Japanese women
    Kasahara, Yoshio
    Kawai, Masaaki
    Tsuji, Ichiro
    Tohno, Eriko
    Yokoe, Takao
    Irahara, Minoru
    Tangoku, Akira
    Ohuchi, Noriaki
    BREAST CANCER, 2013, 20 (04) : 310 - 315
  • [29] Screening Mammography Among Older Women: A Review of United States Guidelines and Potential Harms
    Mack, Deborah S.
    Lapane, Kate L.
    JOURNAL OF WOMENS HEALTH, 2019, 28 (06) : 820 - 826
  • [30] Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening
    Mandrik, Olena
    Zielonke, Nadine
    Meheus, Filip
    Severens, J. L.
    Guha, Neela
    Acosta, Rolando Herrero
    Murillo, Raul
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (04) : 994 - 1006